NWAG
GILD icon

Net Worth Advisory Group’s Gilead Sciences GILD Stock Holding History

Net Worth Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,771
Closed -$247K – 426
2026
Q1 		$247K Buy
+1,771
New +$248K 0.05% 366
2025
Q4 		– Sell
-8,892
Closed -$987K – 459
2025
Q3 		$987K Sell
8,892
-457
-5% -$51.9K 0.29% 67
2025
Q2 		$1.04M Buy
9,349
+389
+4% +$41.4K 0.23% 85
2025
Q1 		$1M Buy
8,960
+34
+0.4% +$3.51K 0.32% 54
2024
Q4 		$824K Buy
8,926
+67
+0.8% +$6.03K 0.25% 79
2024
Q3 		$743K Buy
+8,859
New +$676K 0.22% 103

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Net Worth Advisory Group's GILD Position: Q2 2026 in Review

Net Worth Advisory Group sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,771 shares — an estimated $247K sold.

Net Worth Advisory Group first reported a position in GILD in Q3 2024 and held it in 6 quarters. The position peaked at $1.04M in Q2 2025. 2,272 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Net Worth Advisory Group reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Net Worth Advisory Group sold 1,771 Gilead Sciences shares in Q2 2026, an estimated $247K.
  • Net Worth Advisory Group first reported a position in Gilead Sciences in Q3 2024 and held it in 6 quarters.
  • Net Worth Advisory Group's Gilead Sciences position peaked at $1.04M in Q2 2025.
  • 2,272 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.